{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:49:57Z","timestamp":1791355797953,"version":"4.3.1"},"reference-count":48,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The prognosis for patients with B-cell chronic lymphocytic leukemia (B-CLL) is generally less favorable for those expressing CD38. Our working hypothesis is that CD38 is not merely a marker in B-CLL, but that it plays a receptor role with pathogenetic potential ruling the proliferation of the malignant clone. CD38 levels were generally low in the patients examined and monoclonal antibody (mAb) ligation was inefficient in signaling. Other cellular models indicated that molecular density and surface organization are critical for CD38 functionality. Interleukin 2 (IL-2) induced a marked up-modulation and surface rearrangement of CD38 in all the patients studied. On reaching a specific expression threshold, CD38 becomes an efficient receptor in purified B-CLL cells. Indeed, mAb ligation is followed by Ca2+ fluxes and by a markedly increased proliferation. The unsuitability of CD38 to perform as a receptor is obviated through close interaction with the B-cell\u2013receptor (BCR) complex and CD19. On mAb binding, CD38 translocates to the membrane lipid microdomains, as shown by a colocalization with the GM1 ganglioside and with CD81, a raft-resident protein. Finally, CD38 signaling in IL-2\u2013treated B-CLL cells prolonged survival and induced the appearance of plasmablasts, providing a pathogenetic hypothesis for the occurrence of Richter syndrome.<\/jats:p>","DOI":"10.1182\/blood-2003-03-0989","type":"journal-article","created":{"date-parts":[[2003,5,27]],"date-time":"2003-05-27T00:16:07Z","timestamp":1053994567000},"page":"2146-2155","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":152,"title":["CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells"],"prefix":"10.1182","volume":"102","author":[{"given":"Silvia","family":"Deaglio","sequence":"first","affiliation":[{"name":"From the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, Research Center on Experimental Medicine (CeRMS), and the Department of Medicine and Experimental Oncology, University of Torino Medical School, Italy; Department of Hematology, University Hospital, Essen, Germany; and Bone Marrow Transplant Center, \u201cBianchi Melacrino Morelli\u201d Hospital, Reggio Calabria, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Capobianco","sequence":"additional","affiliation":[{"name":"From the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, Research Center on Experimental Medicine (CeRMS), and the Department of Medicine and Experimental Oncology, University of Torino Medical School, Italy; Department of Hematology, University Hospital, Essen, Germany; and Bone Marrow Transplant Center, \u201cBianchi Melacrino Morelli\u201d Hospital, Reggio Calabria, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Bergui","sequence":"additional","affiliation":[{"name":"From the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, Research Center on Experimental Medicine (CeRMS), and the Department of Medicine and Experimental Oncology, University of Torino Medical School, Italy; Department of Hematology, University Hospital, Essen, Germany; and Bone Marrow Transplant Center, \u201cBianchi Melacrino Morelli\u201d Hospital, Reggio Calabria, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Du\u0308rig","sequence":"additional","affiliation":[{"name":"From the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, Research Center on Experimental Medicine (CeRMS), and the Department of Medicine and Experimental Oncology, University of Torino Medical School, Italy; Department of Hematology, University Hospital, Essen, Germany; and Bone Marrow Transplant Center, \u201cBianchi Melacrino Morelli\u201d Hospital, Reggio Calabria, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunato","family":"Morabito","sequence":"additional","affiliation":[{"name":"From the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, Research Center on Experimental Medicine (CeRMS), and the Department of Medicine and Experimental Oncology, University of Torino Medical School, Italy; Department of Hematology, University Hospital, Essen, Germany; and Bone Marrow Transplant Center, \u201cBianchi Melacrino Morelli\u201d Hospital, Reggio Calabria, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Du\u0308hrsen","sequence":"additional","affiliation":[{"name":"From the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, Research Center on Experimental Medicine (CeRMS), and the Department of Medicine and Experimental Oncology, University of Torino Medical School, Italy; Department of Hematology, University Hospital, Essen, Germany; and Bone Marrow Transplant Center, \u201cBianchi Melacrino Morelli\u201d Hospital, Reggio Calabria, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Malavasi","sequence":"additional","affiliation":[{"name":"From the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, Research Center on Experimental Medicine (CeRMS), and the Department of Medicine and Experimental Oncology, University of Torino Medical School, Italy; Department of Hematology, University Hospital, Essen, Germany; and Bone Marrow Transplant Center, \u201cBianchi Melacrino Morelli\u201d Hospital, Reggio Calabria, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021217504084600_REF1","doi-asserted-by":"crossref","unstructured":"Rozman C, Montserrat E. Chronic lymphocytic leukemia. N Engl J Med. 1995;333: 1052-1057.","DOI":"10.1056\/NEJM199510193331606"},{"key":"2020021217504084600_REF2","doi-asserted-by":"crossref","unstructured":"Chiorazzi N, Ferrarini M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol. 2003;21: 841-894.","DOI":"10.1146\/annurev.immunol.21.120601.141018"},{"key":"2020021217504084600_REF3","doi-asserted-by":"crossref","unstructured":"Caligaris-Cappio F, Hamblin TJ. B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol. 1999;17: 399-408.","DOI":"10.1200\/JCO.1999.17.1.399"},{"key":"2020021217504084600_REF4","doi-asserted-by":"crossref","unstructured":"Damle RN, Fais F, Ghiotto F, et al. Chronic lymphocytic leukemia: a proliferation of B cells at two distinct stages of differentiation. Curr Top Microbiol Immunol. 2000;252: 285-292.","DOI":"10.1007\/978-3-642-57284-5_29"},{"key":"2020021217504084600_REF5","doi-asserted-by":"crossref","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94: 1848-1854.","DOI":"10.1182\/blood.V94.6.1848"},{"key":"2020021217504084600_REF6","doi-asserted-by":"crossref","unstructured":"Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94: 1840-1847.","DOI":"10.1182\/blood.V94.6.1840"},{"key":"2020021217504084600_REF7","doi-asserted-by":"crossref","unstructured":"Ibrahim S, Keating M, Do KA, et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood. 2001;98: 181-186.","DOI":"10.1182\/blood.V98.1.181"},{"key":"2020021217504084600_REF8","doi-asserted-by":"crossref","unstructured":"Morabito F, Mangiola M, Oliva B, et al. Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia. Leuk Res. 2001; 25: 927-932.","DOI":"10.1016\/S0145-2126(01)00049-2"},{"key":"2020021217504084600_REF9","doi-asserted-by":"crossref","unstructured":"Durig J, Naschar M, Schmucker U, et al. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Leukemia. 2002; 16: 30-35.","DOI":"10.1038\/sj.leu.2402339"},{"key":"2020021217504084600_REF10","doi-asserted-by":"crossref","unstructured":"Hamblin TJ, Orchard JA, Ibbotson RE, et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood. 2002;99: 1023-1029.","DOI":"10.1182\/blood.V99.3.1023"},{"key":"2020021217504084600_REF11","unstructured":"Morabito F, Mangiola M, Stelitano C, Deaglio S, Callea V, Malavasi F. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil. Haematologica. 2002;87: 217-218."},{"key":"2020021217504084600_REF12","doi-asserted-by":"crossref","unstructured":"Deaglio S, Mehta K, Malavasi F. Human CD38: a (r)evolutionary story of enzymes and receptors. Leuk Res. 2001;25: 1-12.","DOI":"10.1016\/S0145-2126(00)00093-X"},{"key":"2020021217504084600_REF13","unstructured":"Deaglio S, Malavasi F. Human CD38: a receptor, an (ecto)enzyme, a disease marker and lots more. Mod Aspects Immunobiol. 2002;2: 121-125."},{"key":"2020021217504084600_REF14","doi-asserted-by":"crossref","unstructured":"Campana D, Suzuki T, Todisco E, Kitanaka A. CD38 in hematopoiesis. Chem Immunol. 2000; 75: 169-188.","DOI":"10.1159\/000058768"},{"key":"2020021217504084600_REF15","doi-asserted-by":"crossref","unstructured":"Kumagai M, Coustan-Smith E, Murray DJ, et al. Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med. 1995;181: 1101-1110.","DOI":"10.1084\/jem.181.3.1101"},{"key":"2020021217504084600_REF16","doi-asserted-by":"crossref","unstructured":"Zupo S, Rugari E, Dono M, Taborelli G, Malavasi F, Ferrarini M. CD38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells. Eur J Immunol. 1994;24: 1218-1222.","DOI":"10.1002\/eji.1830240532"},{"key":"2020021217504084600_REF17","doi-asserted-by":"crossref","unstructured":"Deaglio S, Morra M, Mallone R, et al. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol. 1998;160: 395-402.","DOI":"10.4049\/jimmunol.160.1.395"},{"key":"2020021217504084600_REF18","doi-asserted-by":"crossref","unstructured":"Deaglio S, Mallone R, Baj G, et al. CD38\/CD31, a receptor\/ligand system ruling adhesion and signaling in human leukocytes. Chem Immunol. 2000;75: 99-120.","DOI":"10.1159\/000058765"},{"key":"2020021217504084600_REF19","doi-asserted-by":"crossref","unstructured":"Morra M, Zubiaur M, Terhorst C, Sancho J, Malavasi F. CD38 is functionally dependent on the TCR\/CD3 complex in human T cells. FASEB J. 1998;12: 581-592.","DOI":"10.1096\/fasebj.12.7.581"},{"key":"2020021217504084600_REF20","doi-asserted-by":"crossref","unstructured":"Deaglio S, Zubiaur M, Gregorini A, et al. Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells. Blood. 2002;99: 2490-2498.","DOI":"10.1182\/blood.V99.7.2490"},{"key":"2020021217504084600_REF21","doi-asserted-by":"crossref","unstructured":"Deaglio S, Mallone R, Baj G, et al. Human CD38 and its ligand CD31 define a unique lamina propria T lymphocyte signaling pathway. FASEB J. 2001;15: 580-582.","DOI":"10.1096\/fj.00-0522fje"},{"key":"2020021217504084600_REF22","doi-asserted-by":"crossref","unstructured":"Funaro A, De Monte LB, Dianzani U, Forni M, Malavasi F. Human CD38 is associated to distinct molecules which mediate transmembrane signaling in different lineages. Eur J Immunol. 1993;23: 2407-2411.","DOI":"10.1002\/eji.1830231005"},{"key":"2020021217504084600_REF23","doi-asserted-by":"crossref","unstructured":"Lund FE, Yu N, Kim KM, Reth M, Howard MC. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression. J Immunol. 1996;157: 1455-1467.","DOI":"10.4049\/jimmunol.157.4.1455"},{"key":"2020021217504084600_REF24","doi-asserted-by":"crossref","unstructured":"Zubiaur M, Fernandez O, Ferrero E, et al. CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt\/PKB and Erk activation in the absence of the CD3-{zeta} immune receptor tyrosine-based activation motifs. J Biol Chem. 2001;277: 13-22.","DOI":"10.1074\/jbc.M107474200"},{"key":"2020021217504084600_REF25","doi-asserted-by":"crossref","unstructured":"Berditchevski F. Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci. 2001;114: 4143-4151.","DOI":"10.1242\/jcs.114.23.4143"},{"key":"2020021217504084600_REF26","doi-asserted-by":"crossref","unstructured":"Claas C, Stipp CS, Hemler ME. Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts. J Biol Chem. 2001;276: 7974-7984.","DOI":"10.1074\/jbc.M008650200"},{"key":"2020021217504084600_REF27","doi-asserted-by":"crossref","unstructured":"Cheng PC, Brown BK, Song W, Pierce SK. Translocation of the B cell antigen receptor into lipid rafts reveals a novel step in signaling. J Immunol. 2001;166: 3693-3701.","DOI":"10.4049\/jimmunol.166.6.3693"},{"key":"2020021217504084600_REF28","doi-asserted-by":"crossref","unstructured":"Pierce SK. Lipid rafts and B-cell activation. Nat Rev Immunol. 2002;2: 96-105.","DOI":"10.1038\/nri726"},{"key":"2020021217504084600_REF29","doi-asserted-by":"crossref","unstructured":"Zupo S, Massara R, Dono M, et al. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD. Blood. 2000;95: 1199-1206.","DOI":"10.1182\/blood.V95.4.1199.004k21_1199_1206"},{"key":"2020021217504084600_REF30","doi-asserted-by":"crossref","unstructured":"Savarino A, Bensi T, Chiocchetti A, et al. Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120. FASEB J. 2003;17: 461-463.","DOI":"10.1096\/fj.02-0512fje"},{"key":"2020021217504084600_REF31","doi-asserted-by":"crossref","unstructured":"Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194: 1625-1638.","DOI":"10.1084\/jem.194.11.1625"},{"key":"2020021217504084600_REF32","doi-asserted-by":"crossref","unstructured":"Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194: 1639-1647.","DOI":"10.1084\/jem.194.11.1639"},{"key":"2020021217504084600_REF33","doi-asserted-by":"crossref","unstructured":"Durig J, Nuckel H, Huttmann A, et al. Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia. Blood. 2003;101: 2748-2755.","DOI":"10.1182\/blood-2002-09-2683"},{"key":"2020021217504084600_REF34","doi-asserted-by":"crossref","unstructured":"Wiestner A, Rosenwald A, Barry TS, et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood. 2003;101: 4944-4951.","DOI":"10.1182\/blood-2002-10-3306"},{"key":"2020021217504084600_REF35","doi-asserted-by":"crossref","unstructured":"Lande R, Urbani F, Di Carlo B, et al. CD38 ligation plays a direct role in the induction of IL-1beta, IL-6, and IL-10 secretion in resting human monocytes. Cell Immunol. 2002;220: 30-38.","DOI":"10.1016\/S0008-8749(03)00025-X"},{"key":"2020021217504084600_REF36","doi-asserted-by":"crossref","unstructured":"Zubiaur M, Fernandez O, Ferrero E, et al. CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt\/protein kinase B and Erk activation in the absence of the CD3-zeta immune receptor tyrosine-based activation motifs. J Biol Chem. 2002;277: 13-22.","DOI":"10.1074\/jbc.M107474200"},{"key":"2020021217504084600_REF37","doi-asserted-by":"crossref","unstructured":"Cragg MS, Chan HT, Fox MD, et al. The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis. Blood. 2002;100: 3068-3076.","DOI":"10.1182\/blood.V100.9.3068"},{"key":"2020021217504084600_REF38","doi-asserted-by":"crossref","unstructured":"Tangye SG, Avery DT, Deenick EK, Hodgkin PD. Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses. J Immunol. 2003;170: 686-694.","DOI":"10.4049\/jimmunol.170.2.686"},{"key":"2020021217504084600_REF39","doi-asserted-by":"crossref","unstructured":"Tangye SG, Avery DT, Hodgkin PD. A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells. J Immunol. 2003;170: 261-269.","DOI":"10.4049\/jimmunol.170.1.261"},{"key":"2020021217504084600_REF40","doi-asserted-by":"crossref","unstructured":"Hamblin TJ, Orchard JA, Gardiner A, Oscier DG, Davis Z, Stevenson FK. Immunoglobulin V genes and CD38 expression in CLL. Blood. 2000;95: 2455-2457.","DOI":"10.1182\/blood.V95.7.2455"},{"key":"2020021217504084600_REF41","doi-asserted-by":"crossref","unstructured":"Ghia P, Strola G, Granziero L, et al. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22. Eur J Immunol. 2002;32: 1403-1413.","DOI":"10.1002\/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO;2-Y"},{"key":"2020021217504084600_REF42","unstructured":"Morabito F, Callea I, Rodino A, et al. Modulation of purine analogs- and chlorambucil-induced cytotoxicity by alpha-interferon and interleukin-2 in chronic lymphocytic leukemia. Leukemia. 1995;9: 1450-1455."},{"key":"2020021217504084600_REF43","doi-asserted-by":"crossref","unstructured":"Granziero L, Ghia P, Circosta P, et al. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood. 2001;97: 2777-2783.","DOI":"10.1182\/blood.V97.9.2777"},{"key":"2020021217504084600_REF44","unstructured":"Morabito F, Mangiola M, Stelitano C, Deaglio S, Callea V, Malavasi F. Simultaneous expression of CD38 and its ligand CD31 by chronic lymphocytic leukemia B-cells: anecdotal observation or pathogenetic hypothesis for the clinical outcome? Haematologica. 2003;88: 354-355."},{"key":"2020021217504084600_REF45","doi-asserted-by":"crossref","unstructured":"Vallario A, Chilosi M, Adami F, et al. Human myeloma cells express the CD38 ligand CD31. Br J Haematol. 1999;105: 441-444.","DOI":"10.1111\/j.1365-2141.1999.01321.x"},{"key":"2020021217504084600_REF46","doi-asserted-by":"crossref","unstructured":"Ferrero E, Saccucci F, Malavasi F. The human CD38 gene: polymorphism, CpG island, and linkage to the CD157 (BST-1) gene. Immunogenetics. 1999;49: 597-604.","DOI":"10.1007\/s002510050654"},{"key":"2020021217504084600_REF47","doi-asserted-by":"crossref","unstructured":"Behar E, Chao NJ, Hiraki DD, et al. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. N Engl J Med. 1996;334: 286-291.","DOI":"10.1056\/NEJM199602013340502"},{"key":"2020021217504084600_REF48","doi-asserted-by":"crossref","unstructured":"Gao C, Sun W, Christofidou-Solomidou M, et al. PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis. Blood. 2003;102: 169-179.","DOI":"10.1182\/blood-2003-01-0003"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/6\/2146\/1690687\/h81803002146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/6\/2146\/1690687\/h81803002146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T09:16:14Z","timestamp":1682500574000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/102\/6\/2146\/17178\/CD38-is-a-signaling-molecule-in-Bcell-chronic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,15]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,9,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-03-0989","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,15]]}}}